Federal Judge Delays Mifepristone Lawsuit Until After Midterms, Impacting Access to Abortion Medication A federal judge has delayed a lawsuit related to mifepristone until after November's midterm elections.
The decision has sent shockwaves through the reproductive healthcare community and potentially affects access to abortion medication. Mifepristone is a cornerstone of medical abortions, approved by the FDA in 2000.
It works by blocking progesterone receptors, inhibiting fetal growth, and causing a miscarriage.